Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21.
Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21.
复制标题
DOI:
10.1053/j.gastro.2013.10.059
复制
发表时间:
2014-02
期刊:
影响因子:
29.4
通讯作者:
Zang M
中科院分区:
文献类型:
--
作者:
Li Y;Wong K;Giles A;Jiang J;Lee JW;Adams AC;Kharitonenkov A;Yang Q;Gao B;Guarente L;Zang M
The hepatocyte-derived hormone fibroblast growth factor 21 (FGF21) is a hormone-like regulator of metabolism. The NAD+-dependent deacetylase SIRT1 regulates fatty acid metabolism through multiple nutrient sensors. Hepatic overexpression of SIRT1 reduces steatosis and glucose intolerance in obese mice. We investigated mechanisms by which SIRT controls hepatic steatosis in mice. Mice with liver-specific disruption of Sirt1 (SIRT1 LKO mice) and their wild-type littermates (controls) were divided into groups that were placed on normal chow diets, fasted for 24 hrs, or fasted for 24 hrs and then fed for 6 hrs. Liver tissues were collected and analyzed by histologic, gene expression profile, and real-time PCR assays. Human HepG2 cells were incubated with pharmacologic activators of SIRT1 (resveratrol or SRT1720) and assessed by mitochondrial oxidation and immunoblot analyses. FGF21 was overexpressed in SIRT1 LKO mice using an adenoviral vector. Energy expenditure was assessed by indirect calorimetry. Fasting induced lipid deposition in livers of control mice, but severe hepatic steatosis in SIRT1 LKO mice. Gene expression analysis showed that fasting upregulated FGF21 in livers of control, but not SIRT1 LKO mice. Decreased hepatic and circulating levels of FGF21 in fasted SIRT1 LKO mice were associated with reduced hepatic expression of genes involved in fatty acid oxidation and ketogenesis, and increased expression of genes that control lipogenesis, compared with fasted control mice. Resveratrol or SRT1720 each increased transcriptional activity of the FGF21 promoter (–2070/+117) and levels of FGF21 mRNA and protein in HepG2 cells. Surprisingly, SIRT1 LKO mice developed late-onset obesity with impaired whole-body energy expenditure. Hepatic overexpression of FGF21 in SIRT1 LKO mice increased expression of genes that regulate fatty acid oxidation, decreased fasting-induced steatosis, reduced obesity, increased energy expenditure, and promoted browning of white adipose tissue. SIRT1-mediated activation of FGF21 prevents liver steatosis caused by fasting. This hepatocyte-derived endocrine signaling appears to regulate expression of genes that control a brown fat-like program in white adipose tissue, energy expenditure, and adiposity. Strategies to activate SIRT1 or FGF21 might be used to treat fatty liver disease and obesity.
登录
查看更多内容
影响因子:
3.5
作者:
Izumiya, Yasuhiro;Bina, Holly A.;Ouchi, Noriyuki;Akasaki, Yuichi;Kharitonenkov, Alexei;Walsh, Kenneth
通讯作者:
Walsh, Kenneth
影响因子:
4.8
作者:
Ponugoti, Bhaskar;Kim, Dong-Hyun;Kemper, Jongsook Kim
通讯作者:
Kemper, Jongsook Kim
影响因子:
10.5
作者:
Chen, Danica;Bruno, Joanne;Guarente, Leonard
通讯作者:
Guarente, Leonard
影响因子:
5.6
作者:
Kharitonenkov, Alexei;Dunbar, James D.;Shanafelt, Armen B.
通讯作者:
Shanafelt, Armen B.
影响因子:
29
作者:
Banks AS;Kon N;Knight C;Matsumoto M;Gutiérrez-Juárez R;Rossetti L;Gu W;Accili D
通讯作者:
Accili D